Phase III safety study of cell-based versus egg-derived trivalent influenza vaccine in healthy children and adolescents

Phase 3, randomised, single-blind trial in influenza comparing Cell-based trivalent influenza vaccine with Egg-derived trivalent influenza vaccine (Fluvirin) (2 arms). Primary endpoint: Number of subjects reporting solicited local adverse events, solicited systemic adverse events, and other indicators of reactogenicity after any vaccination.